{"id":49600,"date":"2026-08-03T15:39:00","date_gmt":"2026-08-03T13:39:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=40ea3d4d20f86c69ad2e1e770c6c41e1"},"modified":"2026-08-03T15:39:00","modified_gmt":"2026-08-03T13:39:00","slug":"u-s-urology-partners-names-jonathan-coggins-coo","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=49600","title":{"rendered":"U.S. Urology Partners Names Jonathan Coggins COO"},"content":{"rendered":"

NASHVILLE, Tenn.--(BUSINESS WIRE)--U.S. Urology Partners<\/a> announced today that Jonathan Coggins<\/a> has joined the rapidly growing organization<\/a> as Chief Operating Officer. Coggins is a strategy and operations leader experienced in driving growth and operational performance across large-scale, multisite healthcare organizations.<\/p><\/a><\/a>

\nWith a network of more than 70 locations<\/a> across six states, U.S. Urology Partners<\/a> continues to play a key role in advancing innovation and access to urological services. As a partner<\/a> to independent, community-based urology practices, U.S. Urology Partners enables them to focus on delivering premier care to the patients they serve and is backed by leading global investor General Atlantic<\/a>.<\/p>

\nCoggins<\/a> assumes the role from longtime U.S. Urology Partners executive Mandy Lawrence<\/a>, who will serve as Chief Experience Officer<\/a>, a critical new C-suite position. With a nursing degree and an MBA, Lawrence<\/a> will focus on designing a more seamless, compassionate and coordinated patient journey to ensure patients receive the highest-quality, evidence-based care.<\/p>

\nCorina Tracy, Chief Executive Officer of U.S. Urology Partners<\/a>, stated, \u201cWe are pleased to welcome Jonathan Coggins<\/a> as Chief Operating Officer. Jonathan brings a proven record of leading strategy, growth and operational performance across healthcare organizations, and his experience is strongly aligned with our work to support independent, community-based urology practices<\/a>. His leadership will help advance our best-in-class, integrated healthcare platform<\/a> and further our purpose<\/a> of enabling physicians to focus on delivering the most effective, efficient and innovative urologic care, while strengthening the capabilities practices need to grow and thrive.\u201d<\/p>

\nJonathan Coggins, Chief Operating Officer<\/a>, stated, \"U.S. Urology Partners<\/a> has built something rare\u2014a platform<\/a> that lets independent urology practices stay independent while giving physicians the resources to grow<\/a> and patients the highest level of care. I'm excited to partner with our practice leaders to build on that foundation and help even more communities<\/a> access outstanding urologic care.\"<\/p>

\nAs Chief Operating Officer of U.S. Urology Partners, Coggins<\/a> leads the company's operational strategy and execution across its network of affiliated urology practices<\/a>, partnering with practice leadership to strengthen operations, drive growth and deliver an exceptional patient experience.<\/p>

\nCoggins<\/a> joins U.S. Urology Partners from McKesson Corporation, where he most recently served as Senior Vice President, Strategy and Operations. In that role he set the strategic roadmap spanning McKesson's U.S. Oncology Network and Provider Solutions businesses. He also launched McKesson's first fintech and money-services offering for community-based practices and built Clarity Solutions, the company's device group purchasing organization, from the ground up.<\/p>

\nBefore McKesson, Coggins was part of the PricewaterhouseCoopers and Accenture advisory services business, where he supported more than 100 M&A transactions and post-merger integrations for corporate and private equity clients. Coggins holds a Master of Healthcare Administration from Oklahoma State University's College of Health Sciences and a Bachelor of Business Administration from the University of Arizona.<\/p>

\nU.S. Urology Partners helps<\/a> urology practices of all sizes retain independence and deliver quality care while practicing medicine in their preferred community-based setting. The company supports its affiliated groups<\/a> with deep expertise in business operations, data insights and technology infrastructure to drive improved patient outcomes and satisfaction and to alleviate the substantial administrative burdens that lead to burnout for many providers. U.S. Urology Partners also invests<\/a> in end-to-end clinical capabilities for both cutting-edge genitourinary oncology \u2013 primarily cancer of the prostate, kidney and bladder \u2013 and non-oncology treatment pathways.<\/p>

\nMore detailed information about the U.S. Urology Partners leadership team <\/a>can be found at www.us-uro.com\/our-team<\/a>.<\/p>

\nAbout U.S. Urology Partners<\/b><\/p>

\nU.S. Urology Partners<\/a> offers a comprehensive suite of practice management capabilities<\/a> to its affiliated community-based urology practices<\/a>, which maintain their local brand and identity that they have established, often over decades. U.S. Urology Partners currently supports six affiliated groups<\/a> across a network of more than 70 locations in Florida<\/a>, Indiana<\/a>, Massachusetts<\/a>, New Jersey<\/a>, New York<\/a>, Ohio<\/a> and Pennsylvania<\/a>. For more information, please visit www.us-uro.com<\/a>.<\/p> Contacts<\/b>

\nLaura Campbell , CEO\nLaura Campbell & Associates\n615.579.6599\nlaura@laura-campbell.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NASHVILLE, Tenn.–(BUSINESS WIRE)–U.S. Urology Partners announced today that Jonathan Coggins has joined the rapidly growing organization as Chief Operating Officer. Coggins is a strategy and operations leader experienced in driving growth and operati…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-49600","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/49600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49600"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/49600\/revisions"}],"predecessor-version":[{"id":49602,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/49600\/revisions\/49602"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}